share

Derek H. Jones - Curriculum Vitae

NAME

Derek Hunter Jones, M.D.

ADDRESS

9201 W. Sunset Blvd. Suite 602, Los Angeles, CA 90069
Telephone: 310-246-0495 Facsimile: 310-246-0496

LICENSURE

California, #A62154
New York, #200652-1
Hawaii, #15056
DEA #BJ4863634

BOARD CERTIFICATION

Diplomate, American Board of Dermatology, 1997
Recertified, American Board of Dermatology, January 2008

EDUCATION

Baylor College of Medicine, Houston, Texas
Doctor of Medicine, May 1993

Tufts University, Medford, Massachusetts
Bachelor of Science, Biology/Psychology, magna cum laude, May 1987

TRAINING

Columbia College of Physicians and Surgeons, New York, New York
Chief Resident in Dermatology, July 1995 - June 1997;
Resident in Dermatology, July 1994 - June 1995

Baylor College of Medicine Affiliated Hospitals, Houston, Texas
Internship in Internal Medicine, July 1993 - June 1994

PROFESSIONAL PRACTICE

Founder and Director, Skin Care and Laser Physicians of Beverly Hills, 1997 - present.

ACADEMIC APPOINTMENT

Clinical Associate Professor in Medicine, Dermatology Division
David Geffen School of Medicine, University of California at Los Angeles

MEMBERSHIPS, BOARDS and COMMITTEES

Fellow, American Academy of Dermatology, 1999-present.
Fellow, American Society for Dermatologic Surgery, 1999-present.
Editorial Board , Dermatologic Surgery , 2010-present.
Editorial Board, Journal of Cosmetic and Laser Therapy, 2006-present.
Preceptor, ASDS Preceptorship Program.
American Society for Dermatologic Surgery, Patient Education Product Development Work Group, 2004-2007.
American Society for Dermatologic Surgery, New Technologies Work Group, 2006-2009.
American Academy of Dermatology, Post Graduate Education Committee, 2006-2009.
American Society for Dermatologic Surgery: Postgraduate Education Work Group, 2008-2010.
Scientific Reputation Task Work Group, American Society for Dermatologic surgery, 2010-present.
American Society for Dermatologic Surgery: Chair, Postgraduate Education Work Group, 2010-present.
American Society for Dermatologic Surgery: Chair, Member Engagement Work Group, 2010-present.
American Society for Dermatologic Surgery: Industry Relations Council, 2011-present.
American Society for Dermatologic Surgery: Future Leaders Network, Mentor, 2014-present.
American Society for Dermatologic Surgery: Board of Directors, 2014-present.

PUBLICATIONS

  1. Jones D, Levy ML. Cutaneous Manifestations of Pediatric Human Immunodeficiency Virus Syndrome and Minor Sexually Transmitted Diseases. Seminars in Pediatric Infectious Diseases 1993; 4(3): 199-201.
  2. Dozier SE, Diven DG, Jones D, Brysk M, Sanchez RL, Motamedi M. The Q-Switched Alexandrite Laser's Effects on Tattoos in Guinea Pigs and Harvested Human Skin. Dermatol Surg 1995; 21: 237-240.
  3. Jones D, Kay M, Craigen W, MaCabe E, Hawkins H, Dominey A. Coal black hyperpigmentation at birth in a child with congenital adrenal hypoplasia. J Am Acad Dermatol 1995: 323-6.
  4. Massey R, Jones D, Diamond J, Eliezri Y, Katz B.The importance of patient selection in CO2 laser skin resurfacing. Cosmetic Dermatology 1997; 10 (2): 10-14.
  5. Jones D, Grossman M. Dilantin-like hypersensitivity associated with lamotrigine. J Am Acad Dermatol 1997; 36: 1016-1018.
  6. Jones D, Beltrani V. Mucous membrane contact dermatitis. Immunology and Allergy Clinics of North America 1997; 17(3): 471-485.
  7. DeLeo VA, Altman E, Christiani A, Jones D, Michael E, Perez M, Reichel M, Tok J: Structure, Function, and Immunology of the Skin. Allergy: Principles and Practice. 5th edition, Mosby: St. Louis, 1998.
  8. Jones D. What's New in Cosmetic Dermatology: 1998. Skin and Aging 1998; 6 (12).
  9. Jones D. HIV Dermatology 2000. SearchLight, AIDS Research All., Winter 2000.
  10. Jones D. Commentary on HIV Lipodystrophy: Review of the Syndrome and Report of a Case, by M. Chastain et al; Dermatologic Surgery (2001; 27:497-500).
  11. Jones D. Injectable Silicone for Facial Lipoatrophy. Cosmetic Dermatology 2002: 15:13-15.
  12. Jones D. Liquid Injectable Silicone. Dialogues in Dermatology. American Academy of Dermatology, Nov, 2003.
  13. Iyer S, Jones D. Community Acquired Methicillin-Resistant Staphylococcus aureus Skin Infection: A Retrospective Analysis of Prevalence, Clinical Presentation, and Treatment of a Local Epidemic. Journal of American Academy of Dermatology, 2004: 50 (6); 854-858.
  14. Jones D, Carruthers A, Orentreich D, Brody H, et al. Highly Purified 1000 cs Silicone Oil for Treatment of HIV-associated Facial Lipoatrophy: An Open Pilot Trial. Dermatologic Surgery 2004; 30:1279-1286.
  15. Orentreich D, Jones D. Liquid Injectable Silicone. In Carruthers A, Carruthers J (Editors). Procedures in Cosmetic Dermatology: Soft Tissue Augmentation, Elsevier-Saunders, 2005.
  16. Jones D. HIV Facial Lipoatrophy: Causes and Treatment. Dermatologic Surgery, 2005; 31:11 (part 2): 1519-1529.
  17. Jones D. Approaches to Treatment of Facial Lipoatropy. Skin Therapy Letter, J Dover and M Alam, Eds. 2005; Vol 10 (9).
  18. Jones D. Facial Lipoatrophy: Etiology and Methods of Correction. Tissue Augmentation in Clinical Practice 2nd Edition. Arnold Klein, Editor(2006). New York, NY: Taylor and Francis Group.
  19. Wildemore J, Jones D. Persistent Granulomatous Inflammatory Response Induced by Poly-L-lactic Acid for HIV lipoatrophy. Dermatologic Surgery, 2006; 32:1407-1409
  20. Prather C, Jones D. Liquid Injectable Silicone for Soft Tissue Augmentation. Dermatologic Therapy, 2006; 19(3):159-168.
  21. Jones D, Vleggaar D. Technique for Injecting Poly-L-lactic acid. Journal of Drugs in Dermatology, 2007; 6(1) Supplement: s13-s17.
  22. Jones D. Late appearing abscesses after Bio-Alcamid Injections for HIV-associated facial lipoatrophy. Dermatologic Surgery, 2007; 33(s2): S193-198.
  23. Prather C, Jones D. Liquid Injectable Silicone. In Carruthers A, Carruthers J (Editors). Procedures in Cosmetic Dermatology: Soft Tissue Augmentation, 2nd Edition, Elsevier-Saunders, 2007.
  24. Jones D. Soft Tissue Augmentation. In Goldberg D (Editor), Facial Rejuvenation, a Total Approach; Springer 2007.
  25. Jones D. Commentary on Accurate and Anatomic Midface Filler Injection by Using Cheek Implants as an Injection Template. Dermatologic Surgery, 2008; 34(1), p 96.
  26. Jones D. Commentary on Improvement of nasolabial fold correction with non-animal stabilized hyaluronic acid (NASHA) 100,000 gel particles/mL filler on 2 retreatment schedules. Dermatologic Surgery, 2008; 34:S1, p S8.
  27. Jones D. Commentary on Evaluation of Injectable CaHA for the treatment of HIV-Associated Facial Lipoatrophy. Dermatologic Surgery, 2008, 34:11; 1498-1499.
  28. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Rating Scale for Forehead Lines. Dermatologic Surgery 2008; 33(s2): s155-160.
  29. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Lip Fullness Rating Scale. Dermatologic Surgery 2008; 33(s2); s161-166.
  30. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Brow Positioning Grading Scale. Dermatologic Surgery 2008; 33(s2); s150-154.
  31. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Rating Scale for Marionette Lines. Dermatologic Surgery; 2008; 33(s2); s167-172.
  32. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Hand-Grading Scale. Dermatologic Surgery 2008; 33(s2): s179-183.
  33. Carruthers A, Carruthers J, Hardas B, Jones D, et al. A Validated Rating Scale for Crow's Feet . Dermatologic Surgery 2008; 33(s2): s173-178.
  34. Jones D. Liquid Inejctable Silicone for the Upper Third of the Face. In Pearls and Pitfalls in Cosmetic Oculoplastic Surgery. Hartstein M, Holds J, Massry G, Sengleman R, eds. Springer, 2009.
  35. Jones D. Semi-permanent and Permanent Fillers. Dermatologic Clinics, Volume 27 (4), October, 2009.
  36. Rotunda A, Jones D. HIV-Associated Lipohypertrophy (buccal fat pad lipoma-like lesions) reduced with Subcutaneously Injected Sodium Deoxycholate. Dermatologic Surgery 2010; 36(8):1348-1354.
  37. Narins R, Coleman W, Donofrio L, Jones D, Mass C, Monheit G, Kuar M, Grundy SL, Pappert EJ, Hardas B. Nonanimal Sourced Hyaluronic Acid-Based Dermal Filler Using a Polydensified Matrix Technology is Superior to Bovine Collagen in the Correction of Moderate to Severe Nasolabial Folds: Results from a 6-Month, Randomized, Blinded, Controlled, Multicenter Study. Dermatologic Surgery, Volume 36 (s1): 730-740, April 2010.
  38. Jones D, Tezel A, Borell M. In-Vitro Resistance to Degradation of HA by Ovine Testicular Hyaluronidase. Dermatologic Surgery. Volume 36 (s1): 804-809, April 2010.
  39. Jones D, Saghari S. Collagen based fillers. In Office Cosmetic Procedures- A Practical Manual. Eremia S, Editor. Cambridge University Press, 2010.
  40. Jones D. Textbook Editor: Injectable Fillers: Principles and Practice. Wiley-Blackwell, 2010.
  41. Jones D, Flynn T. Hyaluronic acids: Clinical Applications. In Injectable Fillers: Principles and Practice, Derek Jones, MD, Editor. Wiley-Blackwell, 2010.
  42. Sadick N, Prather C, Jones D. Silicone. In Augmentation Fillers. Sadick N, Editor. Cambridge University Press 2010.
  43. Beynet D, Jones D, Flynn T. Fillers and Botulinum Toxin in Facial Resurfacing. In Facial Resurfacing, Goldberg D, Editor. Wiley Blackwell, 2010.
  44. Jones D. Permanent Fillers. In Cosmetic Bootcamp Primer, Beer K, Lupo M, Narukar V, Editors. Informa UK Limited, 2010.
  45. Flynn TC, Jones D: "Fillers and fat transfer for treatment of acne scarring," in Tosti, De Padova, Beer (eds): Acne Scars. London, Informa Healthcare, Chapter 8, pp 49-56, 2010.
  46. Jones D. Enhanced Eyelashes: Prescription and Over the Counter Options. Aesthetic Plastic Surgery 2011; 35 (1): 116-121.
  47. Smith S, Jones D, Thomas J. Duration of wrinkle correction following repeat treatment with Juvederm hyaluronic acid fillers. Arch Dermatol Res 2010; 302 (10): 757-762.
  48. Narins R, Coleman W, Donofrio L, Jones D, Maas C, Monheit G, Kaur M, Grundy S, Pappert E, Hardas B. Improvement in Nasolabial Folds with Hyaluronic Acid Filler Using a Cohesive Polydensified Matrix Technology: Results from an 18-Month Open-Label Extension Trial. Dermatologic Surgery 2010;36:1800-1808
  49. Jones D. Are Aesthetic Grading Scales only a Research Tool?. Dermatologic Surgery 2010;36:1817-1818
  50. Jones D. New Option for Facial Volume: Volumizing with a 20mg/mL Smooth, Highly Cohesive, Viscous Hyaluronic Acid Filler and Its Role in Facial Rejuvenation Therapy. Dermatologic Surgery 2010;36:1893-1894
  51. Jones D. What Lies Beneath. Dermatologic Surgery 2011; 37:3, p 387-388.
  52. Jones D. Volumizing the Face with Soft Tissue Fillers. Clinics in Plastic Surgery: Cosmetic Medicine and Minimally Invasive Surgery 2011; 38:3, p 379-390
  53. Jones D. Liquid Injectable Silicone and Polymethylmethacrylate. In Dermatologic Surgery-Step by Step, Nouri K, Editor. Wiley-Blackwell, 2010.
  54. Jones D. Collyer J, Injectable Fillers for augmentation of the Cheeks and Nasolabial Folds. In Total Esthetic Approach to Clinical Face and Body Rejuvenation. Kim J, Lask G, Neison A, Editors. Informa Healthcare, 2012.
  55. Carruthers J, Flynn T, Geister T, Gortelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, Maio M, Mohrmann C, Narins R, Pooth R, Rzany B, Sattler G, Buchner L, Benter U, Breitscheidel L, Carruthers A. Validated Assessment Scales for the Upper Face. Dermatologic Surgery 2012; 38 p 309-319
  56. Carruthers J, Flynn T, Geister T, Gortelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, Maio M, Mohrmann C, Narins R, Pooth R, Rzany B, Sattler G, Buchner L, Benter U, Breitscheidel L, Carruthers A. Validated Assessment Scales for the Mid Face. Dermatologic Surgery 2012; 38 p 320-332.
  57. Carruthers J, Flynn T, Geister T, Gortelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, Maio M, Mohrmann C, Narins R, Pooth R, Rzany B, Sattler G, Buchner L, Benter U, Breitscheidel L, Carruthers A. Validated Assessment Scales for the Lower Face. Dermatologic Surgery 2012; 38 p 333-342.
  58. Rzany R, Carruthers A, Carruthers J, Flynn T, Geister T, Gortelmeyer R, Hardas B, Himmrich S, Jones D, Mario M, Mobrmann C, Narins R, Pooth R, Sattler G, Buchner L, Merito M, Fey C, Kerscher M. Validated Composite Assessment Scales for the Global Face. Dermatologic Surgery 2012; 294-308.
  59. Sattler G, Carruthers A, Carruthers J, Flynn T, Geister T, Gortelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, Mobrmann C, Narins R, Pooth R, Ryzany B, Buchner L, Benter U, Breitscheidel L, Mario M. Validated Assessment Scale for the Neck Volume. Dermatologic Surgery 2012; 343-350.
  60. Jones D. Mid-Face Volumizing with Calcium Hydroxylapatite. Journal of Drugs in Dermatology 2012; Volume 11: s31-s32
  61. Narins R, Donofrio L, Rubin M, Jones D. Guest Editors, Special issue on Fillers. Dermatologic Surgery Part II; 2012
  62. Jones D. Treatment of HIV Associated Facial Lipoatrophy: 2012 Update. (Commentary on Injectable Poly-L-Latic Acid for Human Immunodeficiency Virus-Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open-Label Study). Dermatologic Surgery 2012; 1206-1207
  63. Jones D. Leveling the Playing Field with Comparative Evidence: Which Hyaluronic Acid Filler Has Superior Efficacy, Safety, and Durability?. (Commentary on A prospective, Split-Face, Randomized, Comparative Study of Safety and 12-Month Longevity of Three Formulations of Hyaluronic Acid Dermal Filler for Treatment of Nasolabial Folds.) Dermatologic Surgery 2012; 1151-1152
  64. Jones D, Wesley N. Glabella. Botulinum Toxin; 3rd Edition Procedures in Cosmetic Dermatology; Edited by Dover S, Alam M, Carruthers J, Carruthers A: 2012; 77-84
  65. Jones D, Brody H. Liquid Injectable Silicone. Soft Tissue Augmentation; 3rd Edition Procedures in Cosmetic Dermatology; Edited by Dover S, Alam M, Carruthers J, Carruthers A: 2012; 62-69
  66. Saedi N, Rotunda A, Jones D, Narins R, Matarasso S. Soft Tissue Augmentation. Volume Two Third Edition Dermatology Edited by Bolognia J, Jorizzo J, Schaffer J. 2012; 2547-2560
  67. Carruthers A, Carruthers J, Coleman W, Donofrio L, Flynn T, Gold M, Heinz M, Harrington L, Jones D, McDaniel D, Rohrer T, Schlobe A, Solish N, Weiss R. Multicenter, Randomized, Phase III Study of a Single Dose of IncobotulinumtoxinA, Free from Complexing Proteins, in the Treatment of Glabellar Frown Lines. Dermatologic Surgery 2013; 39, 551-558
  68. Scali C, Humphrey S, Jones D, Carruthers A. Treatment of Posterior Cheek Enlargement in HIV+ Patients with Botulinum Toxin A. Dermatologic Surgery 2013; 39 (9):1407-10.
  69. Jones D. Gentleman Relax. Commentary on Botulinum Toxin in Men: A review of Relevant Anatomy and Clinical Trial Data. Dermatologic Surgery 2013; 39 (10): 1444-45.
  70. Jones D, Murphy D. Volumizing Hyaluronic Acid Filler for Midface Volume Deficit: 2 year Results from a Pivotal Single-Blind Randomized Controlled Study. Dermatologic Surgery. 2013;39 (11): 1602-11.
  71. Jones D, Carruthers J, Narins R, Coleman W, et al. Efficacy of Incobotulinum toxin A for Treatment of Glabellar Frown Lines: A Post-Hoc Pooled Analysis of Two Randomized, Placebo-Controlled, Phase III Trials. Dermatologic Surgery 2014; 40(7): 776-785.
  72. Glaser D, Jones D, Carruthers J, Largent J, Caulkins C. Epidemiologic Analysis of Eyelash Characteristics with Increasing Age in a Population of Healthy Women. Journal of Dermatologic Surgery 2014; 40(11): 1208-1213.
  73. Jones D. Treatment of Delayed Reactions to Dermal Fillers. Journal of Dermatologic Surgery 2014; 40(11): 1180.
  74. Moers-Carpi M, Carruthers J, Fagien S, Lupo M, Delmar H, Jones D, Somogyi C, Lee E, Lei X, MacKinnon S, Beddingfield F. Efficacy and Safety of Onabotulinum toxin A for Treating Crow's Feet Lines Alone or in Combination With Glabellar Lines: A Multicenter, Radomized, Controlled Trial. Journal of Dermatologic Surgery 2014; 40(11): 1181-1190.
  75. Jones D. Liquid Injectable Silicone for the Upper Third of the Face. In Pearls and Pitfalls in Cosmetic Oculoplastic Surgery, Second Edition. Hartstein M, Massry G, Holds J, eds. Springer, 2015; 487-489.
  76. Kane M, Cox S, Jones D, Lei X, Gallagher J. Heterogeneity of Crow's Feet Line Patterns in Clinical Trial Subjects. Journal of Dermatologic Surgery 2015; 41(4): 447-456.

RESEARCH

  1. Investigator, Rodenstock, Inc. Pre-market study of the clinical utility and applications of computerized, digital microscopy in the detection of malignant melanoma. 2000-2001
  2. Principal Investigator, Abgenix and Quintiles: Protocol ABX-0204: Part II. A two part, multi-center, randomized, double-blind, placebo controlled, multiple dose clinical trial of ABX-IL8 (a monoclonal antibody IL-8 inhibitor) in patients with moderate to severe plaque psoriasis. 2001-2002
  3. Principal Investigator, TEVA Pharmaceuticals. A Multi-Center, Double-Blind Placebo Controlled, Parallel Group Study Comparing Bioequivalence 2 Formulations of Metronidazole Gel 0.075% for Rosacea. 2001-2002
  4. Investigator, RJ Development, Peabody, MA. FDA study investigator for SilSkin (highly purified 1000 cs silicone oil) in treating nasolabial folds, mid-malar depressions, oral commissures, and HIV associated facial lipoatrophy. 2001
  5. Principal Investigator, Inamed/Allergan. Investigator for FDA trials on a new family of hyaluronic acid fillers (JUVEDERM). 2004-2006
  6. Principal Investigator, Merz Pharmaceuticals. Investigator for FDA trials on a new hyaluronic acid filler (Belotero). 2006-2008
  7. Principal Investigator, Allergan. FDA trials on topical bimatoprost solution for eyelash growth. 2007-2008
  8. Principal Investigator, Allergan. FDA trials for hyaluronic acid fillers (JUVEDERM) for perioral and lip rejuvenation. 2007-2008
  9. Principal Investigator, Merz Pharmaceuticals. Investigator for FDA trials on a new hyaluronic acid filler (Belotero Soft) for treatment of mild nasolabial folds. 2008
  10. Principal Investigator, Merz Pharmaceuticals. Investigator for FDA trials on botulinum toxin A (NT 201) for treatment of glabellar furrows. 2008-present.
  11. Lead Investigator, Allergan. Investigator for FDA trials on a new hyaluronic acid (Voluma) for treatment of midface lipoatrophy. 2007-2013.
  12. Lead Investigator, Merz. Pivotal FDA trials on MDF-100 alginate filler for nasolabial folds. 2009.
  13. Principle Investigator, Galderma. Pivotal FDA trials on a new hyaluronic acid filler, Emervel. 2010.
  14. Lead Investigator, Phase 4 Investigator Initiated Trial on Combination of Botox Cosmetic and Juvederm Ultra for Brow Enhancement. 2010-2011.
  15. Principle Investigator, Kythera. Phase 3 study of ATX-101 (sodium deoxycholate injection) versus placebo for the reduction of localized subcutaneous fat in the submental area. 2012- 2014
  16. Principle Investigator, Lithera. Phase 2 study of LIPO-202 (salmeterol xinafoate (SX)) versus placebo for the reduction of localized subcutaneous fat in the abdomen area. 2013- 2014
  17. Principal Investigator, Allergan. Phase 3 study of Latisse (topical bimatoprost solution) versus placebo for eyebrow growth. 2013- 2014
  18. Principal Investigator, Merz. Phase 4 study to investigate the equivalence of incobotulinumtoxinA (Xeomin) to onabotulinumtoxinA (Botox) in the treatment of glabellar frown lines. 2013-2014
  19. Principal Investigator, Kythera. Phase 3B study of ATX-101 (sodium deoxycholate injection) for the reduction of localized subcutaneous fat in the submental area in subjects with clinician reported submental fat rating scale grade 1 or grade 4. 2013
  20. Principal Investigator, Evolus. Phase 3 study of
  21. Principal Investigator, Evolus. Phase 2 study of

PRESENTATIONS and POSTERS

  1. Jones D, Perez M. Mucoepidermoid carcinoma of the hard palate resected utilizing Mohs surgery. American College of Mohs Surgery 1996 annual meeting, Palm Desert, California.
  2. Jones D, Kay M, Craigen W, MaCabe E, Hawkins H, Dominey A. Coal black hyperpigmentation at birth in a child with congenital adrenal hypoplasia. Gross and Microscopic Symposium, 1996 annual meeting of the American Academy of Dermatology, Washington, D.C
  3. Jones D. Vesicular cheilitis in association with parvovirus B-19 induced glove and sock purpura. Gross and Microscopic Symposium, 1997 annual meeting of the American Academy of Dermatology, San Francisco, California
  4. DeMoore GM, Hennessey P, Kunz N, Jones D, Rabkin J. The psychological impact of Kaposi's sarcoma. Poster presentation, International Congress of Dermatology, Sydney, Australia, June 1997.
  5. Jones D, Treatment of lipodystrophy associated with protease inhibitor therapy. Continuing Education Seminar, AIDS Project Los Angeles, June 1998.
  6. Jones D. Accutane and the Primary Care Physician. UCLA Student Health CME Lecture Series for Primary Care Providers, June 1999.
  7. Jones D. Cosmetic Problems in the HIV Patient. Guest Lecturer, Grand Rounds, St. Lukes/Roosevelt Affiliated Hospitals, Columbia University, Dept. of Dermatology, NY, NY. Oct 18, 2001.
  8. Jones D. Treatment of Facial Lipoatrophy. Guest Lecturer, Grand Rounds, UCLA AIDS Institute, Los Angeles, CA, Nov 2, 2001.
  9. Jones D. Treatment Options for Facial Lipoatrophy. AIDS Healthcare Foundation, Los Angeles Intercity Rounds, Los Angeles, CA, Nov 16, 2001.
  10. Jones D. Treatment of Facial Lipoatrophy. Lecture in course on Soft Tissue Augmentation, American Academy of Dermatology Annual Meeting, New Orleans, LA. February 2002.
  11. Jones D. Treatment Options for Facial Lipoatrophy. Lecture for HIV Matters, sponsored by the Jeffrey Goodman Clinic, Los Angeles, CA, June 11, 2002.
  12. Jones D. Fillers for Skin of Color. Defining Skin of Color Symposium, Sponsored by the Skin and Color Institute, Columbia University, New York, New York, June 16, 2002.
  13. Jones D. Grand Rounds, Department of Dermatology, UCLA. Treatment options for HIV associated facial lipoatrophy. July 2002.
  14. Jones D. Temporary Treatment Options for HIV Facial Lipoatrophy. Presented at Forum on HIV Lipoatrophy, AAD Summer Academy, NY, NY August 3, 2002.
  15. Jones D. Treatment Options for HIV Facial Lipoatrophy. APLA Community Seminar, Los Angeles, CA. August 20, 2002.
  16. Jones D. Treatment options for HIV Associated Lipoatrophy. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 2002.
  17. Jones D. Liquid Injectable Silicone for HIV Lipoatrophy. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 2002.
  18. Jones D. Treatment Options for HIV facial Lipoatrophy. Presented at Symposium for Tower Infectious Disease Group, November 12, 2002.
  19. Jones, D. Treatment of HIV associated facial lipoatrophy. 3rd Annual International Conference on Adverse Drug Reactions and Lipodystrophy. San Diego, CA. November 2002.
  20. Jones D. SilSkin for treatment of HIV lipoatrophy. Being Alive symposium for Facial Reconstruction of lipoatrophy. San Diego, CA. November 2002.
  21. Jones D. Liquid Injectable Silicone, History and Cosmetic Uses. Lecture in Soft Tissue Augmentation Course. American Academy of Dermatology Annual Meeting, San Francisco, CA March 2003.
  22. Jones D. Focus Session: Treatment Options for HIV Associated Lipoatrophy. American Academy of Dermatology Annual Meeting, San Francisco, CA March 2003.
  23. Jones D. Grand Rounds, Department of Dermatology, UCLA. Cosmetic uses of liquid injectable silicone. October 2003.
  24. Jones D. Results at 1 year in 100 patients treated with liquid injectable silicone for HIV associated lipoatrophy. American Society for Dermatologic Surgery, New Orleans, LA October 2003.
  25. Jones D. Non-Invasive Facial Rejuvenation. Sponsored by Medicis, as training session for Restylane. Pasadena, CA, January 2004.
  26. Jones D. Cosmetic Botox in Men. In "Botox Update" course. American Academy of Dermatology Annual Meeting, Washington, DC February 2004.
  27. Jones D. Focus Session: Treatment Options for HIV Associated Lipoatrophy. American Academy of Dermatology Annual Meeting, Washington, DC, February 2004.
  28. Jones, D. Silicone study for HIV Facial Lipoatrophy. Cosmetic Dermatology Symposium, Skin Disease Education Foundation, Orlando Florida, May 13, 2004.
  29. Jones, D. Highly purified 1000 cs liquid injectable silicone for HIV associated facial lipoatrophy. Changing the Face of HIV. Joint Program of UCSD and Being Alive, San Diego. June 15, 2004.
  30. Jones D. Treatment Options for HIV Facial Lipoatrophy. Presented at "New Solutions to Old Problems, Optimal Management of the Sequelae of Long-term HIV Infection and Chronic Antiretroviral Therapy", presented by the UCLA AIDS Institute, June 18, 2004
  31. Jones D, Bauman L. Breakthroughs in Facial Rejuvenation. Laguna, CA , June 19, 2004. Sponsored by Inamed as training session for Hylaform.
  32. Jones D. Treatment of Facial Lipoatrophy. Pacific Dermatologic Society Annual Meeting, August 14, 2004, Newport Beach, CA.
  33. Jones D. Liquid Injectable Silicone. ASDS Filler Course. Los Angeles, CA August 21,2004.
  34. Jones D. Liquid Injectable Silicone. ASDS Filler Course. San Francisco, CA. August 28, 2004
  35. Jones D. Botox Update. Guest speaker for the Los Angeles Metropolitan Dermatological Society monthly meeting. October 26, 2004.
  36. Jones D. Combination Use of Fillers. Presented on behalf of Inamed for the Los Angeles 2004 Cosmetic Expo. November 6, 2004
  37. Jones D. Hyaluronic Acid. Presentation for the American Society of Cosmetic Dermatology and Aesthetic Surgery. Phoenix, AZ. December 3, 2004.
  38. Jones D. Treatment of Facial Lipoatrophy. Presented at the "Focus on the Future" Symposium produced by the UCLA AIDS Institute and Cedars-Sinai Medical Center. January 13, 2005.
  39. Jones D. The New World of Fillers. Presented at the 2005 Caribbean Dermatology Symposium, Aruba. January 21, 2005.
  40. Jones D. Combination use of Fillers. Presented at the 2004 "Breakthroughs in Cosmetic Surgery" Symposium, Los Angeles, CA. January 23, 2005.
  41. Jones D. Liquid Injectable Silicone for Facial Lipoatrophy. Presented by Being Alive. Los Angeles. February 16, 2005.
  42. Jones D. Focus Session: Treatment Options for Facial Lipoatrophy. Presented at the 2005 AAD Annual Meeting, New Orleans, LA. February 18, 2005
  43. Jones D. Fillers to treat large facial areas such as lipoatrophy. Soft Tissue Augmentation Course, 2005 AAD Annual Meeting, New Orleans, LA. February 18, 2005.
  44. Jones D. Botox in Men. Botox Update Forum, 2005 AAD Annual Meeting, New Orleans, LA. February 18, 2005.
  45. Jones, D. Silicone. Cosmetic Dermatology Symposium, Skin Disease Education Foundation, Anaheim, CA, May 13, 2005.
  46. Jones, D. The New World of Fillers. Presented at Grand Rounds, UCLA Division of Dermatology, July 5, 2005.
  47. Jones, D. Basic Dermoscopy. Lecture presented to UCLA Dermatology Residents, UCLA Division of Dermatology, July 5, 2005.
  48. Jones D. Liquid injectable silicone for lipoatrophy. In Controversies in Silicone Course, Annual Meeting of the American Society for Dermatologic Surgery. Atlanta, Georgia, October 2005.
  49. Jones D. Panelist, Live Surgery Course. Annual Meeting of the American Society for Dermatologic Surgery. Atlanta, Georgia, October 2005.
  50. Jones D. Advances in Reconstruction of Facial Lipoatrophy. CME seminar supported by an unrestricted grant from Dermik. Westwood, CA, December, 2005.
  51. Jones D. Poly-L-Lactic Acid for Facial Volume Loss. Presented at the Skin Disease Education Foundation 30th Annual Hawaii Dermatology Seminar, Kauai, Hawaii, February 11, 2006.
  52. Jones D. Poly-L-Lactic Acid. Presented in Visual Learning Session, Skin Disease Education Foundation 30th Annual Hawaii Dermatology Seminar, Kauai, Hawaii, February 12, 2006.
  53. Jones D. Silicone Injections in 2006. Presented at the Skin Disease Education Foundation 30th Annual Hawaii Dermatology Seminar, Kauai, Hawaii, February 17, 2006.
  54. Jones D. Lip Augmentation: Volume vs. Structure. Presented at the Skin Disease Education Foundation 30th Annual Hawaii Dermatology Seminar, Kauai, Hawaii, February 17, 2006.
  55. Jones D. Director, "Fillers" Forum Session. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 3, 2006.
  56. Jones D. Poly-L-Lactic Acid for Facial Volume Loss. Presented in "Fillers" Forum Session. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 3, 2006.
  57. Jones D. Combined Fillers for Lip Augmentation. Presented in "Fillers" Forum Session. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 3, 2006.
  58. Jones D. Selecting the Appropriate Filler is Key to Successful Treatment. Media Briefing. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 3, 2006.
  59. Jones D. HIV Lipoatrophy. Presented in AIDS and STD Session. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 4, 2006.
  60. Jones D. Live injection session, faculty and treating physician. Basic Botulinum Toxin Course. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 4, 2006.
  61. Jones D. Silicone for Facial Lipoatrophy. Presented in Silicone Forum. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 4, 2006.
  62. Jones D. Silicone. Skin Disease Education Foundation's Cosmetic Dermatology Seminar, Phoenix Arizona, May 3-7, 2006.
  63. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, June 8, 2006, Anaheim, CA.
  64. Jones D. Choosing the best filler for each patient, in Cosmetic Dermatology Symposium. American Academy of Dermatology Annual Summer Academy Meeting, July 27th, 2006, San Diego, CA.
  65. Stacy Smith, Jones D, et al. Poster presentation: Efficacy and safety following repeat treatment for a new family of hyaluronic acid based fillers. Presented at the Academy, 06 meeting of the American Academy of Dermatology; July 26th-30th, 2006; San Diego, CA
  66. Jones D. Faculty, ISCLS Master's Series workshop in cosmetic and laser surgery, Aug 3-5, 2006, Los Angeles, CA. (UCLA Div. of Derm. hosted).
  67. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, August 11, 2006, Houston, TX.
  68. Jones D. Choosing the right filler for each patient. 58th Annual Meeting of the Pacific Dermatological Association, August 13, 2006, Monterey, CA.
  69. Jones D. Faculty and treating physician for live injection session for Allergan's national Manager's training, August 29, 2006, Anaheim, CA.
  70. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, September 18, 2006, Beverly Hills, CA.
  71. Jones D. Faculty and treating physician for live injection demonstration for Allergan's National Education Faculty Training, September 23, 2006, Dana Point, CA.
  72. Jones D. Liquid Injectable Silicone. Forum session at American Society for Dermatologic Surgery Annual Meeting, October 26, 2006, Palm Springs, CA.
  73. Jones D. Faculty and treating physician for live injection training sessions at American Society for Dermatologic Surgery, October 27 and 28, 2006, Palm Springs, CA.
  74. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, November 4, 2006, Atlanta, GA.
  75. Jones D. Silicone vs. Temporary Fillers. International Masters Course on Aging Skin, January 11, 2007, Paris, France.
  76. Jones D. Botox: Dosing and Aesthetic Considerations in the Male Patient. International Masters Course on Aging Skin, January 11, 2007, Paris, France.
  77. Jones D. Long Durability and non-resorbable fillers: What's new in the US? International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  78. Jones D. FDA efficacy and safety studies of Juvederm for nasolabial fold corrections. International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  79. Jones D. Deoxycholate injections for HIV lipoaccumulation. International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  80. Jones D. Director, Course on facial contouring with fat, injectables and hard implants. International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  81. Jones D. Facial contouring with liquid injectable silicone vs. calcium hydroxylapetite vs. polylactic acid. International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  82. Stacy Smith, Jones D, et al. Poster presentation: Efficacy and safety following repeat treatment for a new family of hyaluronic acid based fillers. International Masters Course on Aging Skin (IMCAS), January 12, 2007, Paris, France.
  83. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, January 27, 2007, Newport Beach, CA.
  84. Jones D. Liquid Injectable Silicone: Past, present and future. Presented in Filler Symposium, American Academy of Dermatology Annual Meeting, Washington, D.C., February 1, 2007.
  85. Jones D. Liquid silicone for facial lipoatrophy. Presented in "Controversies in Silicone" forum, American Academy of Dermatology Annual Meeting, Washington, D.C., February 1, 2007.
  86. Jones D. Director, "Fillers" Forum Session. American Academy of Dermatology Annual Meeting, Washington D.C., February 6, 2007.
  87. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, February 24, 2007, San Antonio, TX.
  88. Jones D. Shaping the Face of Aesthetic Medicine. Faculty for training seminar sponsored by Allergan, March 3, 2007, Memphis, TN.
  89. Jones D. Director, State of the Art: Novel Therapeutics at the Intersection of Cosmetic and Medical Dermatology. Skin Disease Education Foundation, 31st Annual Hawaii Dermatology Seminar, Maui, March 5, 2007.
  90. Jones D. Treatment of HIV lipodystophy. Presented at Skin Disease Education Foundation, 31st Annual Hawaii Dermatology Seminar, Maui, March 5, 2007.
  91. Jones D. Past, Present and Future of Fillers. Presented at Skin Disease Education Foundation, 31st Annual Hawaii Dermatology Seminar, Maui, March 8, 2007.
  92. Jones D. Full Facial Rejuvenation. Portraits in patient satisfaction. A case-based video presentation. Presented at Skin Disease Education Foundation, 31st Annual Hawaii Dermatology Seminar, Maui, March 8, 2007.
  93. Jones D. Faculty, Visual Learning Session, Skin Disease Education Foundation 31st Annual Hawaii Dermatology Seminar, Maui, Hawaii, March 8, 2007.
  94. Jones D. Silicone. Presented at the Skin Disease Education Foundation's Cosmetic Dermatology Seminar, Orlando, FL., May 4, 2007.
  95. Jones D. Chairman, "The New Challenge of Facial Contour Rejuvenation". IMCAS Master Seminars, Paris France, June 1, 2007.
  96. Jones D. Liquid Injectable Silicone vs. Calcium Hydrolxyapetite. IMCAS Master Seminars, Paris France, June 1, 2007.
  97. Jones D. Botox in Male Patients. IMCAS Master Seminars, Paris France, June 1, 2007.
  98. Jones D. Shaping the Face of Aesthetic Medicine: Advanced Techniques. Faculty for training seminar sponsored by Allergan, New Orleans, LA, June 16, 2007.
  99. Jones D. Shaping the Face of Aesthetic Medicine: Advanced Techniques. Faculty for training seminar sponsored by Allergan, Santa Clara, CA, June 24, 2007.
  100. Jones D. Past, Present and Future of Fillers. Grand Rounds Basic and Clinical Sciences Lecture Series, UCLA Division of Dermatology, Los Angeles, CA, August 21, 2007.
  101. Jones D. Reconstructive options for facial lipoatrophy. Presented at the Consensus Summit on HIV Metabolic and Morphologic Abnormalities. Boston, MA, August 18, 2007.
  102. Jones D. Shaping the Face of Aesthetic Medicine: Advanced Techniques. Faculty for training seminar sponsored by Allergan. Garden Grove, CA, August 29, 2007.
  103. Jones D. "Super technician vs. the hybrid physician: Does overspecialization blunt the mind?" in Dermatologic and Laser Controversies, American Society of Dermatologic Surgery Annual Meeting 2007; Chicago, IL, October 12, 2007.
  104. Jones D. Course Co-Director: Advances in Silicone. American Society of Dermatologic Surgery Annual Meeting 2007; Chicago, IL, October 12, 2008.
  105. Jones D. "Managing the Dissatisfied Patient", in All about Botulinum Toxins. American Society of Dermatologic Surgery Annual Meeting 2007; Chicago, IL, October 12, 2007.
  106. Jones D. Shaping the Face of Aesthetic Medicine: Advanced Techniques. Faculty for training seminar sponsored by Allergan. New York, NY, December 1, 2007.
  107. Jones D. Shaping the Face of Aesthetic Medicine: Advanced Techniques. Faculty for training seminar sponsored by Allergan. Los Angeles, CA, December 15, 2007.
  108. Jones D. Chair: Fundamentals: New Developments in Imagery, 10th Annual Meeting, International Master Course on Aging Skin, Paris, France, January 10th, 2008.
  109. Jones D. Co-Chair: Live and Video Demos for what's new lectures: Fillers, Peelings and Mesotherapy, 10th Annual Meeting, International Master Course on Aging Skin, Paris, France, January 11th, 2008.
  110. Jones D. Liquid Silicone for Facial Atrophy, 10th Annual Meeting, International Master Course on Aging Skin, Paris, France, January 11th, 2008.
  111. Jones D. Silicone for facial atrophy, in Silicone Forum, American Academy of Dermatology 66th Annual Meeting San Antonio, TX, February 2nd 2008.
  112. Jones D. Director: Forum Director, Fillers, American Academy of Dermatology 66th Annual Meeting, San Antonio, TX, February 3rd 2008.
  113. Jones D. Sculptra and Silicone: overview and injection techniques. In Soft Tissue Augmentation Course, American Academy of Dermatology 66th Annual Meeting, San Antonio, TX, February 4th 2008.
  114. Jones D. Faculty, Visual Learning Session-Understanding New Aesthetic Techniques through observation, Skin Disease Education Foundation 32nd Annual Hawaii Dermatology Seminar, Kona, Hawaii, March 3rd, 2008.
  115. Jones D. Achieving Consistent Long-Term Outcomes with HA Fillers, Skin Disease Education Foundation 32nd Annual Hawaii Dermatology Seminar, Kona, Hawaii, March 7th, 2008.
  116. Jones D. Course Director: Advances in Cosmetic Dermatology, Skin Disease Education Foundation 32nd Annual Hawaii Dermatology Seminar, Kona, Hawaii, March 7th, 2008.
  117. Jones D. Botulinum Toxin Type A- Finessing the Forehead and Brow, Skin Disease Education Foundation 32nd Annual Hawaii Dermatology Seminar, Kona, Hawaii, March 7th, 2008.
  118. Jones D. "Contouring and Volumizing with Sculptra and LIS", Skin Disease Education Foundation 32nd Annual Hawaii Dermatology Seminar, Kona, Hawaii, March 7th, 2008.
  119. Jones D. Chairman, Managing Atypical and Unusual Cases. Presented in Allergan's "The Science of Rejuvenation" National Exchange Forum, San Diego, CA, March 28-30, 2008.
  120. Jones D. Faculty, National Juvederm Speaker Training Seminar. Las Vegas, NV. May 16th - 18th, 2008.
  121. Jones D. Faculty for "Fillers and Botulinum Toxins: Advanced Techniques" supported by StrataMed and Allergan. Atlanta, GA, June 21, 2008.
  122. Jones D. "Facial Volumizing and Botox in Men". Presented at the annual International Facial Aesthetics Conference and Exhibition, London, England. June 28, 2008.
  123. Jones D. "Botox and Fillers in Beverly Hills: The Celebrity Look". Presented at the annual International Facial Aesthetics Conference and Exhibition, London, England. June 29, 2008.
  124. Jones D. "Semi-Permanent and Permanent Fillers". Presented at the 60th Annual Pacific Dermatological Meeting, San Francisco, CA. August 7, 2008.
  125. Jones D. Faculty for "Fillers and Botulinum Toxins: Advanced Techniques" supported by StrataMed and Allergan. Las Vegas, NV, August 23, 2008.
  126. Jones D. Faculty for "Fillers and Botulinum Toxins: Advanced Techniques" supported by StrataMed and Allergan. September 13, 2008, Boston, MA.
  127. Jones D. Director and Moderator, American Society of Dermatologic Surgery "The Art and Science of Fillers and Injectables". Los Angeles, CA. October 4-5, 2008.
  128. Jones D. Botulinum Toxins Overview. American Society of Dermatologic Surgery "The Art and Science of Fillers and Injectables". Los Angeles, CA. October 4-5, 2008.
  129. Jones D. "Facial Volumizing Techniques". American Society of Dermatologic Surgery "The Art and Science of Fillers and Injectables". Los Angeles, CA. October 4-5, 2008.
  130. Jones D. "Will We Ever Find a Better, More Universal Filler than the Cross Linked Hyaluronic Acid?" In Dermatologic Surgery Controversies. American Society of Dermatologic Surgery 2008 Annual Meeting, Orlando, FL, November 8, 2008.
  131. Jones D. New Validated Aesthetic Rating Scales. In "Latest Research in Fillers and Injectables." American Society of Dermatologic Surgery 2008 Annual Meeting, Orlando, FL, November 9, 2008.
  132. Jones D. "Combination Fillers and Toxins: Product category review, mechanism of action and characteristics of dermal fillers available in the US." At Maui Derm. 2009, Maui, HI, January 30, 2009.
  133. Jones, D. "Combination Fillers and Toxins: The role of facial shaping agents in the context of Non-Surgical Total Facial Rejuvenation. How and why combinations work synergistically." At Maui Derm 2009, Maui, HI, January 30, 2009
  134. Jones, D. Faculty: General Injections Toxins and Fillers; Sessions 1 and 2 and Small Group Training Sessions. At Maui Derm 209, Maui, HI, January 30, 2009.
  135. Jones, D. "Botulinum Toxin for the Peri-orbital area with Video". In Basic Botulinum Toxin Course. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 6, 2009.
  136. Jones D. Course Moderator. Soft Tissue Augmentation Course. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 7, 2009.
  137. Jones, D. "Silicone and Poly-lactic Acid: Emerging Concepts". In Soft Tissue Augmentation Course. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 7, 2009.
  138. Jones, D. "The New Fillers: Better, Safer, or is there Trouble Ahead?" In Hot-Topics Symposium. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 7, 2009.
  139. Jones, D. "Combination Therapy: Fillers, Volumizers and Botulinum Toxin". In Advanced Botulinum Toxin Course. American Academy of Dermatology Annual Meeting, San Francisco, CA. March 9, 2009.
  140. Jones D, In-Vitro Resistance to Degradation of HA by Ovine Testicular Hyaluronidase. Late Breaking Abstract Presentation, American Society for Dermatologic Surgery Annual Meeting, Phoenix, Arizona. October 4, 2009.
  141. Jones D. Enhancement vs. Rejuvenation. Keynote address, Canadian FACE Annual meeting. October 18, 2009.
  142. Jones D. Hyaluronans and Collagen. Presented at Cosmetic Bootcamp University, San Francisco. November 7, 2009.
  143. Jones D. Novabel Unplugged. Presented at IMCAS Annual Meeting, Paris, France. January 9, 2010.
  144. Jones D. Hyaluronans: Basic Science. Presented at Maui Derm, January 27, 2010
  145. Jones D. Periocular Botox. Presented in the Basic Botulinum Course, AAD Annual Meeting in Miami, FL, March 6, 2010.
  146. Jones D. Skin Cancer Presentation for Neutrogena's Skin Health, in conjunction with ASDS, at the Neutrogena Corporation, Los Angeles, CA, May 18th, 2010.
  147. Jones D. What's New in Injectable Fillers? Presented at UCLA Department of Dermatology Grand Rounds. June 8, 2010.
  148. Jones D. Injectable Fillers, What's New? Presented at the annual FACE meeting, London, July 3rd, 2010.
  149. Jones D. Hyaluronic Acid Fillers: Beyond Nasolabial Folds. Presented at the Pacific Dermatological Association's Annual Meeting, Pasadena, CA. August 14, 2010.
  150. Jones, D. Presentation "Hyaluronic Acids" and Faculty for full afternoon of live injection teaching session for Residents. Presented at Cosmetic Boot Camp University, Marina Del Ray, CA. October 30, 2010.
  151. Jones D. Tea with the Masters: Silicone Injections. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 22, 2010.
  152. Jones D. Moderator: Fillers Part I. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 23, 2010.
  153. Jones D. Moderator: Fillers Part II. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 23, 2010.
  154. Jones D. Liquid Injectable Silicone and Novel Permanent Fillers. In Fillers Part II. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 23, 2010.
  155. Jones D. Alginate: European Experience. In Fillers Part II. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 23, 2010
  156. Jones D. A Report of 135 Patients with 5 Year and Beyond Follow Up After Treatment with Highly Purified Liquid Injectable Silicone (LIS) for HIV Associated Facial Lipoatrophy (HIV FLA). American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 24, 2010.
  157. Jones D. Poster Presentation: Hyaluronic Acid is Superior to Collagen in the Correction of Moderate to Severe Nasolabial Folds: Results From a Randomized Blinded, Controlled, Multicenter Trial. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 24, 2010.
  158. Jones D. Poster Presentation: The Use of Hyaluronic Acid in the Treatment of Moderate to Severe Nasolabial Folds: An Analysis of Treatment Longevity in an Open-Label Extension (OLEX) Study. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 24, 2010.
  159. Jones D, Rotunda A. Poster Presentation: HIV-Associated Lipohypertrophy (Buccal Fat Lipoma-Like Lesions) Reduced with Subcutaneously Injected Sodium Deoxycholate. American Society for Dermatologic Surgery Annual Meeting, Chicago, IL October 24, 2010.
  160. Jones, D. Botulinum Toxins Overview. Presented at the ASDS course "Art and Science of Fillers and Injectables." San Francisco, CA. November 20, 2010.
  161. Jones D. My technique for Treating Nasolabial and Periorbital Areas. Presented at the ASDS course "Art and Science of Fillers and Injectables". San Francisco, CA. November 20, 2010.
  162. Jones D. How would you treat this patient? Measures of Age-Related Change. Presented at the ASDS course "Art and Science of Fillers and Injectables". San Francisco, CA. November 21, 2010.
  163. Jones MD. Scientific Chair. The Merz Portfolio: Radiesse and Bocouture. IMCAS Annual Meeting. Paris France. January 8, 2010.
  164. Jones D. Treating the Upper Third of the Face with Botox while Maximizing Brow Elevation. Advanced Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting, New Orleans, LA. February 5, 2011.
  165. Jones D. Botulinum Toxins for Peri-Orbital Area. Presented at the American Academy of Dermatology Annual Meeting, New Orleans, LA. February 7, 2011.
  166. Jones D. Update on Hyaluronic Acid Filling Agents. Presented at the American Academy of Dermatology Annual Meeting, New Orleans, LA. February 7, 2011
  167. Jones D. Options for Mid Face Volumizing. Presented in "Aesthetic Dermatology for the Experienced Session" at the 22nd World Congress of Dermatology. Seoul Korea, May 27, 2011.
  168. Jones D. Hyaluronic Acids: Are They the Only Fillers You Need? Presentation at Summit in Aesthetic Medicine, Dana Point California. June 10, 2011
  169. Jones D. Complications of Toxins. Presentation at Summit in Aesthetic Medicine, Dana Point California. June 11, 2011
  170. Jones D. Complications of Fillers. Presentation at Summit in Aesthetic Medicine, Dana Point California. June 11, 2011
  171. Jones D. Annual London FACE (Facial Aesthetics Conference and Exhibition). Chair of multiple sessions and workshop "Male Facial Contouring using Fillers and Toxins". June 24-26, 2011
  172. Jones D. Faculty, Human Cadaver Facial Dissection Workshop; designed to improve the safety of aesthetic injectables. www.cmecommunity.com. July, 2011
  173. Jones D. Beyond Spackle: Combination Treatment of the Lower Face. CBC, Aspen, CO. July 15, 2011
  174. Jones D. Faculty, Live Injection Session. CBC, Aspen, CO. July 15, 2011.
  175. Jones D. What is the Future of Dermatologic Surgery? Presented at the ASDS course "Practice Management in the Era of Health Care Reform". Washington D.C. November 2, 2011.
  176. Jones D. Stress Reduction and Physician Wellness. Presented at the American Society for Dermatologic Surgery Annual Meeting course "Practice Management in the Era of Health Care Reform". Washington D.C. November 2, 2011.
  177. Jones D. Advanced Fillers: First This, Then Demo's. Presented at the American Society for Dermatologic Surgery Annual Meeting. Washington D.C. November 3, 2011.
  178. Jones D. Physician Extenders in Dermatology. Presented in Controversies in Dermatologic Surgery. American Society for Dermatologic Surgery Annual Meeting. Washington D.C. November 4, 2011.
  179. Jones D. Facial Shaping. Presented at the American Society for Dermatologic Surgery Annual Meeting. Washington D.C. November 5, 2011.
  180. Jones D. Faculty. Faceforward; Advanced Non-Surgical Aesthetic Medicine, Presented by Spire Learning. Los Angeles, CA January 21, 2012.
  181. Jones D. Faculty. Live Demonstration, Maui Derm. Maui, HI February 7, 2012.
  182. Jones D. Faculty. Dermal Fillers Lecture, Maui Derm. Maui, HI February 7, 2012.
  183. Jones D. Options for Mid-Face Volumizing. Presented at Harbor-UCLA Grand Rounds. Torrance, CA. March 15, 2012
  184. Jones D. Faculty. Live Demonstration with Incobotulinum, Presented on Advanced Botulinum Toxin Course. American Academy of Dermatology. San Diego, CA March 16, 2012
  185. Jones D. Faculty. Live Demonstration, Disorders of the Periorbital Region, Presented in Application of Our Aesthetic Toolbox for the Treatment of Medical and Dermatologic Disorders Course. American Academy of Dermatology. San Diego, CA March 17, 2012
  186. Jones D. Faculty. Live Demonstration, Volumizing the Mid-Face, Presented on The State of the Art of Aesthetic Dermatology Course. American Academy of Dermatology. San Diego, CA March 17, 2012
  187. Jones D. 10 Years' Experience with Treatment for HIV Associated Lipoatrophy with Silicone 1000. Presented at the American Academy of Dermatology Annual Meeting. San Diego, CA. March 18, 2012
  188. Jones D. Basic Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting. San Diego, CA. March 20, 2012
  189. Jones D. 'Finessing the Frontailis' Presented on Forehead Injection. American Academy of Dermatology Annual Meeting. San Diego, CA. March 20, 2012
  190. Jones D. Mid-Face Volumizing. Presented at UCLA Grand Rounds. Los Angeles, CA April 4, 2012
  191. Jones D. Moderator, Live Injection Session #2. CBC, Colorado Springs, CO. July 20, 2012.
  192. Jones D. Fillers and Beyond: Mid-Face Volumizing. CBC, Colorado Springs, CO. July 20, 2012
  193. Jones D. Faculty, Live Injection Session #3. CBC, Colorado Springs, CO. July 20, 2012
  194. Jones D. Planning and Patient Assessment: Patient Assessment and Planning. Presented at the Allergan Latin America Scientific Conference. Miami, FL. August 24, 2012.
  195. Jones D. Facial Anatomy and Advanced Injection Technique: Eyebrow Shape and Temples. Presented at the Allergan Latin America Scientific Conference. Miami, FL. August 24, 2012.
  196. Jones D. Facial Anatomy and Advanced Injection Technique: Cheekbones and Midface Volumizing in Different Patient Profiles- Square and Round Face. Presented at the Allergan Latin America Scientific Conference. Miami, FL. August 24, 2012.
  197. Jones D. Facial Anatomy and Advanced Injection Technique: The Use of Hyaluronidase to Manage Complications. Presented at the Allergan Latin America Scientific Conference. Miami, FL. August 24, 2012.
  198. Jones D. Activity: My Clinical Experience with Latisse. Presented at the Allergan Latin America Scientific Conference. Miami, FL. August 25, 2012.
  199. Jones D. Cutaneous Surgery and Aesthetics Symposium: New Options for Facial Volumizing. Presented at the Pacific Dermatological Association's Annual Meeting. Huntington Beach, CA. August 25, 2012.
  200. Jones D. New Applications for Botulinum Toxin. Presented at The 2012 Fall Clinical Dermatology Conference. Las Vegas, NV. October 5, 2012.
  201. Jones D. Faculty. Botulinum Toxin Workshop. Presented at The 2012 Fall Clinical Dermatology Conference. Las Vegas, NV. October 6, 2012.
  202. Jones D. The Hyaluronic Family and Calcium Hydroxylapatite. Presented at the American Society for Dermatologic Surgery Annual Meeting course "The Art and Science of Soft-Tissue Fillers and Neuromodulators". San Diego, CA. November 10, 2012.
  203. Jones D. The Technique for the Perfect Lip. Presented at the American Society for Dermatologic Surgery Annual Meeting course "The Art and Science of Soft-Tissue Fillers and Neuromodulators". San Diego, CA. November 10, 2012.
  204. Jones D. Mid-Face Volumizing. Presented at the American Society for Dermatologic Surgery Annual Meeting course "The Art and Science of Soft-Tissue Fillers and Neuromodulators". San Diego, CA. November 11, 2012.
  205. Jones D. Faculty. Live Injection Fillers. Maui Derm. Maui, HI. January 19, 2013.
  206. Jones D. Abstract: Crow's Feet 099 Poster, Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Crow's Feet Lines Alone or in Combination with Glabellar Lines: A Multicenter Randomized Controlled Tria. Maui Derm. Maui, HI. January 19, 2013.
  207. Jones D. Faculty. Live Demonstration, Advanced Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting. Miami, FL. March 1, 2013.
  208. Jones D. Faculty. Live Demonstration, The State of The Art of Aesthetic Dermatology. Presented at the American Academy of Dermatology Annual Meeting. Miami, FL. March 2, 2013.
  209. Jones D. Faculty. Live Demonstration, Application of Our Aesthetic Toolbox for the Treatment of Medical and Dermatologic Disorders. Presented at the American Academy of Dermatology Annual Meeting. Miami, FL. March 2, 2013.
  210. Jones D. Faculty. Dermatologic Surgery: Cosmetic Tips and Pearls. Presented at the American Academy of Dermatology Annual Meeting. Miami, FL. March 2, 2013.
  211. Jones D. Faculty. Finessing the Fickle and Formidable Frontalis and Basic Botulinum Toxin. The American Academy of Dermatology Annual Meeting. Miami, FL. March 4, 2013.
  212. Glaser A, Jones D, Carruthers J, Largent J, Caulkins C. Abstract: Epidemiologic Analysis of Eyelash Characteristics With Increasing Age in a Population of Healthy Women. Presented at the American Academy of Dermatology Annual Meeting. Miami, FL. March 4, 2013.
  213. Jones D. Faculty, Innovations in Facial Aesthetic Medicine. Satellite Symposium at ASAPS. NY, NY. April 12, 2013.
  214. Jones D. Mid Face. Fillers and Toxins: Video Demonstrations. Vegas Cosmetic Surgery & Aesthetic Dermatology. Las Vegas, NV. June 27, 2013.
  215. Jones D. Moderator. Controversies in Dermatologic Surgery. Presented at the American Society for Dermatologic Surgery Annual Meeting. Chicago, IL. October 4, 2013.
  216. Jones D. Mona Lisa Mastery: Facial Shaping. Presented at the American Society for Dermatologic Surgery Annual Meeting. Chicago, IL. October 5, 2013.
  217. Jones D. Cheek Augmentation with Voluma: Results from the FDA Pivotal Trial. Presented in Cosmetic Oral Abstract Session, American Society for Dermatologic Surgery Annual Meeting. Chicago, IL. October 5, 2013.
  218. Jones D. Heterogeneity of Crow's Feet Line Patterns. Presented in Cosmetic Oral Abstract Session, American Society for Dermatologic Surgery Annual Meeting. Chicago, IL. October 5, 2013.
  219. Jones D. Cheek Augmentation with Voluma: Results from the FDA Pivotal Trial. Presented in the Hot Topics Session, American Society for Plastic Surgery Annual Meeting. San Diego, CA. October 11, 2013.
  220. Jones D. Faculty, Innovations in Facial Aesthetic Medicine. Satellite Symposium at ASPS Annual Meeting, San Diego, CA. October 13, 2013.
  221. Jones D. Cheek Augmentation with Voluma: Results from the FDA Pivotal Trial. American Academy of Facial Plastic Surgery and Reconstruction Annual Meeting. San Diego, CA. October 19, 2013.
  222. Jones D. New Indications for Botulinum Toxin. American Academy of Facial Plastic Surgery and Reconstruction Annual Meeting. San Diego, CA. October 19, 2013.
  223. Jones D. Faculty. Live Demonstration, Innovations in Facial Aesthetic Medicine. Satellite Symposium at ASPS, Pasadena, CA. October 23, 2013.
  224. Jones D. Evolution of Injectable Fillers: State of the Art 2013. NYU Grand Rounds. NY, NY. October 25, 2013.
  225. Jones D. Long Standing Fillers and Implants: Silicone, Volumizing HA and Permanent Implants. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 26, 2013.
  226. Jones D. Marketing Procedures to Your Patients. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 26, 2013.
  227. Jones D. My Technique for Treating the Forehead and Glabellar Regions. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 26, 2013.
  228. Jones D. My Technique for Midface Volumizing and the Nasolabial Fold. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 26, 2013.
  229. Jones D. My Technique for Treating the Neck. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 26, 2013.
  230. Jones D. What's on the Horizon for Dermal Fillers and Botulinum Toxins? Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 27, 2013.
  231. Jones D. Advanced Techniques: The Non-Surgical Lift. Presented at American Society for Dermatologic Surgery, The Art and Science of Soft-Tissue Fillers and Neuromodulators. NY, NY. October 27, 2013.
  232. Jones D. Update and New Indications for Botulinum Toxins, Workshop on Soft Tissue Fillers and Botulinum Toxins. Harvard Medical School. Boston, MA. November 9, 2013.
  233. Jones D. Moderator. Economic Reality: Getting the Best out of a Single Syringe. Presented at MAEXS Expert Summit. Paris, France. November 16, 2013.
  234. Jones D. Live Injector. From Injector to Artist: The Upper Face. Presented at MAEXS Expert Summit. Paris, France. November 16, 2013.
  235. Jones D. Moderator. Globalization to Injection Excellence: 3 Experts, 3 Ways. Presented at MAEXS Expert Summit. Paris, France. November 17, 2013.
  236. Jones D. Live Demonstration. Cutting Edge Strategies in Injectable Procedures. Juvederm Voluma / Radiesse Filler (Cheeks, Cheekbone and Chin) Presented at Orlando Dermatology Aesthetic and Clinical (ODAC). Orlando, FL. January 17, 2014.
  237. Jones D. KOL Panel: What is the Future Landscape of Dermatology. Presented at Orlando Dermatology Aesthetic and Clinical (ODAC). Orlando, FL. January 18, 2014.
  238. Jones D. Hands-on Aesthetic Training: Fillers, Neurotoxins, Combination Treatments and Avoiding Complications. Presented at Orlando Dermatology Aesthetic and Clinical (ODAC). Orlando, FL. January 20, 2014.
  239. Jones D. Faculty. Fillers and Toxins. Presented at Maui Derm. Maui HI. January 27, 2014
  240. Jones D. Clinical Trials in Aesthetic Dermatology. Presented at UCLA Grand Rounds. Los Angeles, CA March 6, 2014
  241. Jones D. Live Demonstration: The Challenging Neck. Soft Tissue Augmentation and Neuromodulators-Simultaneous Cadaver Prosection and Live Patient Injections. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 21, 2014.
  242. Jones D. Poster Presentation: Efficacy of Neotensil. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 21, 2014.
  243. Jones D. Expert Injections with Onabotulinum Toxin: Advanced Botulinum Toxin Course. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 22, 2014.
  244. Jones D. Peri-Orbital: Pears, Pitfalls, Product Preferences: Avoiding and Managing Filler Complications Course. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 22, 2014.
  245. Jones D. Avoiding vascular compromise with midface volumizing, avoiding sensory and motor nerve damage with midface volumizing, avoiding parotid damage with midface volumizing: Dermatologic Surgery Cosmetic Tips and Pearls Course. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 23, 2014.
  246. Jones D. Director: Finessing the Forehead: Basic Botulinum Toxin Course. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 24, 2014.
  247. Jones D. Differentiating Botulinum Toxin Type A, Preparations: Basic and Clinical Science: Basic Botulinum Toxin Course. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 24, 2014.
  248. Jones D. Poster Presentation: Efficacy and Safety of ATX-101. Presented at the American Academy of Dermatology Annual Meeting. Denver, CO. March 24, 2014.
  249. Jones D. It's Belotero Time! How Science Translates into Attractiveness. Presented at the Anti-Aging Medicine World Congress Meeting. Monte Carlo, FR. April 4, 2014.
  250. Jones D. Faculty. The Art and Science of the Aesthetic Analysis. Presented at the Understanding the Diversity of HA Fillers: An Innovative Approach to Maximizing Facial Beauty. NY, NY. April 12, 2014.
  251. Jones D. New Options for Mid-Facial Volumizing. Presented at UCLA Grand Rounds. Los Angeles, CA. May 6, 2014.
  252. Jones D. The Value to the Patient and Physician in Implementing Total Face Treatment. Presented at the Asia Pacific Medical Aesthetics Congress. Seoul, Korea. June 6, 2014.
  253. Jones D. Midface: Periorbital, Malar and NLF. Presented at the Asia Pacific Medical Aesthetics Congress. Seoul, Korea. June 6, 2014.
  254. Jones D. Chair. Treatment of the Total Face vs. Individual Sites- Debates and Discussion. Presented at the Asia Pacific Medical Aesthetics Congress. Seoul Korea. June 7, 2014.
  255. Jones D. Total Face: From Theory to Practice in Clinic. Presented at the Asia Pacific Medical Aesthetics Congress. Seoul, Korea. June 7, 2014.
  256. Jones D. Patient Journey & Mastering the Art - My Number 1 'Tip/Technique' Presented at the Asia Pacific Medical Aesthetics Congress. Seoul, Korea. June 7, 2014.
  257. Jones D. Total Face: From Theory to Practice in Clinic. Presented at the Asia Pacific Medical Aesthetics Congress. Shanghai, China. June 11, 2014.
  258. Jones D. Total Face: From Theory to Practice in Clinic. Presented at the Asia Pacific Medical Aesthetics Congress. Beijing, China. June 12, 2014.
  259. Jones D. Faculty. Chair. The Art and Science of the Aesthetic Analysis. Presented at the Understanding the Diversity of HA Fillers: An Innovative Approach to Maximizing Facial Beauty. Chicago, IL. June 28, 2014.
  260. Jones D. Botulinum Toxins: New Indications, New Treatments and Pearls to Reshape the Face and Neck. Presented at the Masters of Aesthetics Symposium. San Diego, CA. August 23, 2014.
  261. Jones D. The Evolution of Injectable Fillers: State of the Art 2014. Mount Sinai Grand Rounds. NY, NY. September 20, 2014.
  262. Jones D. Chair. Achieving Total Facial Rejuvenation. Presented at American Society of Dermatologic Surgery Annual Meeting. San Diego, CA. November 6, 2014.
  263. Jones D. Moderator. Part 2- Mid Face Rejuvenation: Injectable Techniques and Anatomy. Presented at American Society of Dermatologic Surgery Annual Meeting. San Diego, CA. November 7, 2014.
  264. Jones D. The Bone and Retaining Ligaments: Shades of Gray: Know your Anatomy Course. Presented at American Society of Dermatologic Surgery Annual Meeting. San Diego, CA. November 7, 2014.
  265. Jones D. Recognizing and Treatment of Filler Complications: Advanced Fillers: Beyond the Nasolabial Fold Course. Presented at American Society of Dermatologic Surgery Annual Meeting. San Diego, CA. November 8, 2014.
  266. Jones D. Chair. Live Demonstration: Temple Revolumization: Soft Tissue Augmentation and Neuromodulators. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 20, 2015.
  267. Jones D. Poster Presentation. Efficacy and Safety of Incobotulinumboxin A in the Combined Treatment of Upper Facial Lines: Results of the First Prospective, Randomised, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 21, 2015.
  268. Jones D. Director. Live Demonstration: Expert Injections with Onabotulinum Toxin: Advanced Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 21, 2015.
  269. Jones D. Director. Anatomy: Hands-On: Dermal Fillers. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 21, 2015.
  270. Jones D. Director. Basic Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 22, 2015.
  271. Jones D. Finessing the Forehead: Basic Botulinum Toxin. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA. March 22, 2015.
  272. Jones D. Director. Hyaluronidase: An Overview of Undoing and the Overdone: Achieving Natural Looking Results with Cosmetic Treatments. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA March 23, 2015.
  273. Jones D. Director. Cosmetic Tips and Pearls: Avoiding Vascular Accidents in the Temple, Avoiding Vascular Accidents in the Mid Face, Avoiding Vascular Accidents in the Glabella. Presented at the American Academy of Dermatology Annual Meeting. San Francisco, CA March 23, 2015.
  274. Jones D. Chairperson. American Society of Dermatologic Surgery, State of the Art in Minimally Invasive Aesthetics: Global Advances. Presented at the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 8, 2015.
  275. Jones D. Mastering the Medial Cheek and Lid-Cheek Junction: ASDS State of the Art in Minimally Invasive Aesthetics: Global Advances. Presented at the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 8, 2015.
  276. Jones D. Reducing Submental Fat with ATX-101: ASDS State of the Art in Minimally Invasive Aesthetics: Global Advances. Presented at the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 8, 2015.
  277. Jones D. Complications: Preventing them and treating them: Fillers and Toxins II. Presented at the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 12, 2015.
  278. Jones D. Managing Complications of Injectable Fillers: Advanced Dermatologic Surgery. Presented At the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 12, 2015.
  279. Jones D. Voluma Compared to other HA Fillers: Facial Rejuvenation. Presented at the World Congress of Dermatology Annual Meeting. Vancouver, B.C. June 13, 2015.
"WE ARE A PHYSICIAN ONLY PRACTICE OPERATING AT THE FOREFRONT OF AESTHETIC DERMATOLOGY"

  I accept the Terms of Use

 Send promotions

security code

Video Gallery

Get a quick look at why SCLS is so unique.

VIEW VIDEOS

Reduce Unwanted Fat